glp-1 litigation news Lipsitz, Ponterio & Comerford Federal judges consolidate GLP-1 vision
Description
The absolute risk appears to be rare based on clinical trial and post-marketing data
However, once approved, physicians can legally prescribe drugs for off-label uses, as seen with Ozempic and other GLP-1 receptor agonists for weight loss
Rybelsus is licensed in the UK only for treating type 2 diabetes mellitus, not for weight loss
Plus-size influencers have lamented publicly about how marketing agencies, telehealth companies and med spas will reach out to them seeking partnerships or wanting to pay them to promote the drugs
So, how do they stack up
